HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing an underwritten public offering of shares of its common stock or common stock ...
AccurKardia’s FDA-cleared ECG analytics engine, AccurECG™ 2.0, is actively processing live-streaming ECG data for Specialized Medical’s Monitoring System in over 20 clinics and hospitals across four ...
AliveCor announced today that it has received CE mark in Europe for its Kardia 12L electrocardiogram (ECG) system.
AliveCor’s Kardia 12L, a pocket-sized AI ECG system, has received CE Mark for launch in France, Germany, Italy, Spain, and ...
HeartSciences Inc.(Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the ...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining ...
RPMO₂ features a fully embedded oximeter over maxillary dentition, using buccal vestibule mucosa behind the upper lip.
Our hardware-level integration maintains authentication reliability and computational accuracy without traditional ...
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public offering of 12,500,000 ...
Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronisation, according to a Late-Breaking Science presentation at EHRA 2026,1 the annual congress ...
A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results